Hybridoma technology is a new biotechnology approach for commercial production of
Antibiotics
Hybridoma technology is a method for producing large numbers of identical antibodies (also called monoclonal antibodies). This process starts by injecting a mouse with an antigen that provokes in an immune response. A type of white blood cell, the B cell that produces antibodies that bind to the antigen are then harvested from the mouse.